{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:25:40Z","timestamp":1762507540628,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T00:00:00Z","timestamp":1538179200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"publisher","award":["2015.176.1.","2015.176.1."],"award-info":[{"award-number":["2015.176.1.","2015.176.1."]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00259-018-4156-3","type":"journal-article","created":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T13:28:01Z","timestamp":1538227681000},"page":"54-64","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Practice-based evidence for the clinical benefit of PET\/CT\u2014results of the first oncologic PET\/CT registry in Germany"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4080-5850","authenticated-orcid":false,"given":"Christina","family":"Pfannenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Gueckel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergios","family":"Gatidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susann-Cathrin","family":"Olthof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Vach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Reimold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"la Fougere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Martus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,29]]},"reference":[{"issue":"Suppl 2","key":"4156_CR1","doi-asserted-by":"publisher","first-page":"77S","DOI":"10.2967\/jnumed.110.085704","volume":"52","author":"W Vach","year":"2011","unstructured":"Vach W, Hoilund-Carlsen PF, Gerke O, Weber WA. Generating evidence for clinical benefit of PET\/CT in diagnosing cancer patients. J Nucl Med. 2011;52(Suppl 2):77S\u201385S. \n                    https:\/\/doi.org\/10.2967\/jnumed.110.085704\n                    \n                  .","journal-title":"J Nucl Med"},{"issue":"9","key":"4156_CR2","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1007\/s00259-014-2807-6","volume":"41","author":"PF Hoilund-Carlsen","year":"2014","unstructured":"Hoilund-Carlsen PF, Gerke O, Vach W. Demonstrating the benefits of clinical nuclear imaging: is it time to add economic analysis? Eur J Nucl Med Mol Imaging. 2014;41(9):1720\u20132. \n                    https:\/\/doi.org\/10.1007\/s00259-014-2807-6\n                    \n                  .","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"4156_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/bimj.201400020","volume":"57","author":"O Gerke","year":"2015","unstructured":"Gerke O, Hoilund-Carlsen PF, Vach W. Analyzing paired diagnostic studies by estimating the expected benefit. Biom J. 2015;57(3):395\u2013409. \n                    https:\/\/doi.org\/10.1002\/bimj.201400020\n                    \n                  .","journal-title":"Biom J"},{"key":"4156_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s40134-013-0016-x","volume":"1","author":"J Czernin","year":"2013","unstructured":"Czernin J, Allen-Auerbach M, Nathanson D, Herrmann K. PET\/CT in oncology: current status and perspectives. Curr Radiol Rep. 2013;1:177\u201390. \n                    https:\/\/doi.org\/10.1007\/s40134-013-0016-x\n                    \n                  .","journal-title":"Curr Radiol Rep"},{"issue":"9","key":"4156_CR5","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.2967\/jnumed.113.127886","volume":"54","author":"BJ Hillman","year":"2013","unstructured":"Hillman BJ, Frank RA, Abraham BC. The Medical Imaging & Technology Alliance conference on research endpoints appropriate for Medicare coverage of new PET radiopharmaceuticals. J Nucl Med. 2013;54(9):1675\u20139. \n                    https:\/\/doi.org\/10.2967\/jnumed.113.127886\n                    \n                  .","journal-title":"J Nucl Med"},{"issue":"1","key":"4156_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1148\/radiol.2481072190","volume":"248","author":"BJ Hillman","year":"2008","unstructured":"Hillman BJ, Gatsonis CA. When is the right time to conduct a clinical trial of a diagnostic imaging technology? Radiology. 2008;248(1):12\u20135. \n                    https:\/\/doi.org\/10.1148\/radiol.2481072190\n                    \n                  .","journal-title":"Radiology"},{"issue":"1","key":"4156_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1017\/s0266462311000717","volume":"28","author":"LP Staub","year":"2012","unstructured":"Staub LP, Dyer S, Lord SJ, Simes RJ. Linking the evidence: intermediate outcomes in medical test assessments. Int J Technol Assess Health Care. 2012;28(1):52\u20138. \n                    https:\/\/doi.org\/10.1017\/s0266462311000717\n                    \n                  .","journal-title":"Int J Technol Assess Health Care"},{"key":"4156_CR8","first-page":"1125","volume":"41","author":"P Valk","year":"2000","unstructured":"Valk P. Randomized controlled trials are not appropriate for imaging technology evaluation. J Nucl Med. 2000;41:1125\u20136.","journal-title":"J Nucl Med"},{"issue":"4","key":"4156_CR9","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2217\/pme.14.28","volume":"11","author":"T Merlin","year":"2014","unstructured":"Merlin T. The use of the \u2018linked evidence approach to guide policy on the reimbursement of personalized medicines. Personalized Medicine. 2014;11(4):435\u201348.","journal-title":"Personalized Medicine"},{"issue":"8","key":"4156_CR10","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.2967\/jnumed.113.127076","volume":"55","author":"B Siepe","year":"2014","unstructured":"Siepe B, Hoilund-Carlsen PF, Gerke O, Weber WA, Motschall E, Vach W. The move from accuracy studies to randomized trials in PET: current status and future directions. J Nucl Med. 2014;55(8):1228\u201334. \n                    https:\/\/doi.org\/10.2967\/jnumed.113.127076\n                    \n                  .","journal-title":"J Nucl Med"},{"issue":"15","key":"4156_CR11","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1002\/cncr.30672","volume":"123","author":"U Metser","year":"2017","unstructured":"Metser U, Dudebout J, Baetz T, Hodgson DC, Langer DL, MacCrostie P, et al. [(18) F]-FDG PET\/CT in the staging and management of indolent lymphoma: a prospective multicenter PET registry study. Cancer. 2017;123(15):2860\u20136. \n                    https:\/\/doi.org\/10.1002\/cncr.30672\n                    \n                  .","journal-title":"Cancer"},{"key":"4156_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ejca.2016.05.002","volume":"63","author":"IS Ryu","year":"2016","unstructured":"Ryu IS, Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, et al. Impact of (18)F-FDG PET\/CT staging on management and prognostic stratification in head and neck squamous cell carcinoma: a prospective observational study. Eur J Cancer. 2016;63:88\u201396. \n                    https:\/\/doi.org\/10.1016\/j.ejca.2016.05.002\n                    \n                  .","journal-title":"Eur J Cancer"},{"issue":"7","key":"4156_CR13","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1200\/jco.2009.24.6298","volume":"28","author":"M Lonneux","year":"2010","unstructured":"Lonneux M, Hamoir M, Reychler H, Maingon P, Duvillard C, Calais G, et al. Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study. J Clin Oncol. 2010;28(7):1190\u20135. \n                    https:\/\/doi.org\/10.1200\/jco.2009.24.6298\n                    \n                  .","journal-title":"J Clin Oncol"},{"issue":"5","key":"4156_CR14","doi-asserted-by":"publisher","first-page":"756","DOI":"10.2967\/jnumed.116.185587","volume":"58","author":"M Barrio","year":"2017","unstructured":"Barrio M, Czernin J, Fanti S, Ambrosini V, Binse I, Du L, et al. The impact of somatostatin receptor-directed PET\/CT on the management of patients with neuroendocrine tumor: a systematic review and meta-analysis. J Nucl Med. 2017;58(5):756\u201361. \n                    https:\/\/doi.org\/10.2967\/jnumed.116.185587\n                    \n                  .","journal-title":"J Nucl Med"},{"issue":"5","key":"4156_CR15","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s12149-015-0963-9","volume":"29","author":"K Kubota","year":"2015","unstructured":"Kubota K, Matsuno S, Morioka N, Adachi S, Koizumi M, Seto H, et al. Impact of FDG-PET findings on decisions regarding patient management strategies: a multicenter trial in patients with lung cancer and other types of cancer. Ann Nucl Med. 2015;29(5):431\u201341. \n                    https:\/\/doi.org\/10.1007\/s12149-015-0963-9\n                    \n                  .","journal-title":"Ann Nucl Med"},{"issue":"4","key":"4156_CR16","first-page":"492","volume":"43","author":"V Kalff","year":"2002","unstructured":"Kalff V, Hicks RJ, Ware RE, Hogg A, Binns D, McKenzie AF. The clinical impact of (18)F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study. J Nucl Med. 2002;43(4):492\u20139.","journal-title":"J Nucl Med"},{"issue":"1","key":"4156_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2967\/jnumed.114.148247","volume":"56","author":"K Herrmann","year":"2015","unstructured":"Herrmann K, Czernin J, Wolin EM, Gupta P, Barrio M, Gutierrez A, et al. Impact of 68Ga-DOTATATE PET\/CT on the management of neuroendocrine tumors: the referring physician's perspective. J Nucl Med. 2015;56(1):70\u20135. \n                    https:\/\/doi.org\/10.2967\/jnumed.114.148247\n                    \n                  .","journal-title":"J Nucl Med"},{"issue":"11","key":"4156_CR18","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.2967\/jnumed.117.192450","volume":"58","author":"J Calais","year":"2017","unstructured":"Calais J, Czernin J, Eiber M, Fendler WP, Gartmann J, Heaney AP, et al. Most of the intended management changes after (68)Ga-DOTATATE PET\/CT are implemented. J Nucl Med. 2017;58(11):1793\u20136. \n                    https:\/\/doi.org\/10.2967\/jnumed.117.192450\n                    \n                  .","journal-title":"J Nucl Med"},{"issue":"9315","key":"4156_CR19","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/S0140-6736(02)08352-6","volume":"359","author":"H Tinteren van","year":"2002","unstructured":"van Tinteren H, Hoekstra OS, Smit EF, van den Bergh JH, Schreurs AJ, Stallaert RA, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet. 2002;359(9315):1388\u201393.","journal-title":"Lancet"},{"issue":"7","key":"4156_CR20","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.2967\/jnumed.109.063040","volume":"50","author":"TJ Ruers","year":"2009","unstructured":"Ruers TJ, Wiering B, van der Sijp JR, Roumen RM, de Jong KP, Comans EF, et al. Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study. J Nucl Med. 2009;50(7):1036\u201341. \n                    https:\/\/doi.org\/10.2967\/jnumed.109.063040\n                    \n                  .","journal-title":"J Nucl Med"},{"issue":"18","key":"4156_CR21","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1001\/jama.2014.3740","volume":"311","author":"CA Moulton","year":"2014","unstructured":"Moulton CA, Gu CS, Law CH, Tandan VR, Hart R, Quan D, et al. Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases: a randomized clinical trial. JAMA. 2014;311(18):1863\u20139. \n                    https:\/\/doi.org\/10.1001\/jama.2014.3740\n                    \n                  .","journal-title":"JAMA"},{"issue":"13","key":"4156_CR22","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1200\/jco.2007.14.5631","volume":"26","author":"BE Hillner","year":"2008","unstructured":"Hillner BE, Siegel BA, Liu D, Shields AF, Gareen IF, Hanna L, et al. Impact of positron emission tomography\/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET registry. J Clin Oncol. 2008;26(13):2155\u201361. \n                    https:\/\/doi.org\/10.1200\/jco.2007.14.5631\n                    \n                  .","journal-title":"J Clin Oncol"},{"issue":"11","key":"4156_CR23","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.2967\/jnumed.107.043687","volume":"48","author":"BE Hillner","year":"2007","unstructured":"Hillner BE, Liu D, Coleman RE, Shields AF, Gareen IF, Hanna L, et al. The National Oncologic PET registry (NOPR): design and analysis plan. J Nucl Med. 2007;48(11):1901\u20138. \n                    https:\/\/doi.org\/10.2967\/jnumed.107.043687\n                    \n                  .","journal-title":"J Nucl Med"},{"issue":"1","key":"4156_CR24","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1530-9290.2008.00004.x","volume":"12","author":"S Mario","year":"2008","unstructured":"Mario S. The Sankey diagram in energy and material flow management. J Ind Ecol. 2008;12(1):82\u201394. \n                    https:\/\/doi.org\/10.1111\/j.1530-9290.2008.00004.x\n                    \n                  .","journal-title":"J Ind Ecol"},{"issue":"1","key":"4156_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1136\/thorax.58.1.47","volume":"58","author":"GJ Herder","year":"2003","unstructured":"Herder GJ, Van Tinteren H, Comans EF, Hoekstra OS, Teule GJ, Postmus PE, et al. Prospective use of serial questionnaires to evaluate the therapeutic efficacy of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in suspected lung cancer. Thorax. 2003;58(1):47\u201351.","journal-title":"Thorax"},{"issue":"6","key":"4156_CR26","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s00330-010-2025-y","volume":"21","author":"PF Hoilund-Carlsen","year":"2011","unstructured":"Hoilund-Carlsen PF, Gerke O, Vilstrup MH, Nielsen AL, Thomassen A, Hess S, et al. PET\/CT without capacity limitations: a Danish experience from a European perspective. Eur Radiol. 2011;21(6):1277\u201385. \n                    https:\/\/doi.org\/10.1007\/s00330-010-2025-y\n                    \n                  .","journal-title":"Eur Radiol"},{"issue":"33","key":"4156_CR27","doi-asserted-by":"publisher","first-page":"5316","DOI":"10.1200\/jco.2008.18.3996","volume":"26","author":"MN Levine","year":"2008","unstructured":"Levine MN, Julian JA. Registries that show efficacy: good, but not good enough. J Clin Oncol. 2008;26(33):5316\u20139. \n                    https:\/\/doi.org\/10.1200\/jco.2008.18.3996\n                    \n                  .","journal-title":"J Clin Oncol"},{"issue":"3","key":"4156_CR28","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1017\/s0266462313000287","volume":"29","author":"T Merlin","year":"2013","unstructured":"Merlin T, Lehman S, Hiller JE, Ryan P. The \"linked evidence approach\" to assess medical tests: a critical analysis. Int J Technol Assess Health Care. 2013;29(3):343\u201350. \n                    https:\/\/doi.org\/10.1017\/s0266462313000287\n                    \n                  .","journal-title":"Int J Technol Assess Health Care"},{"issue":"8","key":"4156_CR29","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1007\/s00259-017-3674-8","volume":"44","author":"A Forschner","year":"2017","unstructured":"Forschner A, Olthof SC, Guckel B, Martus P, Vach W, la Fougere C, et al. Impact of (18)F-FDG-PET\/CT on surgical management in patients with advanced melanoma: an outcome based analysis. Eur J Nucl Med Mol Imaging. 2017;44(8):1312\u20138. \n                    https:\/\/doi.org\/10.1007\/s00259-017-3674-8\n                    \n                  .","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-018-4156-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-4156-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-4156-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T20:24:42Z","timestamp":1569702282000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-018-4156-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,29]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["4156"],"URL":"https:\/\/doi.org\/10.1007\/s00259-018-4156-3","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"type":"print","value":"1619-7070"},{"type":"electronic","value":"1619-7089"}],"subject":[],"published":{"date-parts":[[2018,9,29]]},"assertion":[{"value":"29 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"K.N. is on the speakers bureau of Bracco, Bayer and Siemens. The institution has cooperative research grants from Bayer and Siemens. All other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.This study was approved by the Ethics committee of the University of Tuebingen, reference number 064\/2013B01.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}